Medical Research
(H30)
990 on File
ROBERT L FINE CANCER RESEARCH LABORATORY FOUNDATION INC
Financial strength (30%)
96/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$262K
Total Revenue
$637K
Total Expenses
$4.9M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
80.5%
Fundraising Efficiency
N/A
Operating Reserve
92.65x
Liability-to-Asset
0.0%
Revenue Diversification
1.3%
Executive Compensation
$40K
Compared with Peers
FY 2025
Compared with 370 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
80.5% | 83.6% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
92.7 mo | 12.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.1% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
1.3% | 91.9% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
26.8% | 4.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.9% | 6.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-142.5% | -1.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $262K | $637K | $4.9M | 80.5% | — |
| 2024 | $207K | $607K | $4.8M | 84.5% | — |
| 2023 | $122K | $330K | $4.6M | 75.8% | — |
| 2022 | $37K | $399K | $4.1M | 78.9% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.